Text and Data Mining valid from 2017-05-11
Received: 7 September 2016
Accepted: 21 February 2017
First Online: 11 May 2017
: C.C. and B.N.C. have filed a patent application for the use of adenosine and A2AR agonists for the treatment of OA which has been assigned to NYU School of Medicine. B.N.C. has consulted for Eli Lilly & Co., Bristol-Myers, Squibb, AstraZeneca and has grants from Celgene and AstraZeneca. The remaining authors declare no competing financial interests.